Key statistics
On Tuesday, Neurogene Inc (NGNE:NMQ) closed at 21.99, 219.85% above the 52 week low of 6.88 set on Apr 08, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 19.87 |
|---|---|
| High | 22.78 |
| Low | 19.43 |
| Bid | 21.00 |
| Offer | 21.98 |
| Previous close | 20.74 |
| Average volume | 295.63k |
|---|---|
| Shares outstanding | 15.49m |
| Free float | 14.13m |
| P/E (TTM) | -- |
| Market cap | 321.26m USD |
| EPS (TTM) | -4.12 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
- Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome
- Neurogene to Participate in Upcoming Investor Conferences
- Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-in-Class Gene Therapy for Rett Syndrome
- Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
More ▼
